BSE filing, NSE: CLEAN. Summary written from the filing by ALFA Finder's alert engine.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹735.35
- Market cap
- ₹7,816 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 33.5×Sector 34.5×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.
Clean Science & Technology Legal & Regulatory
Clean Science concluded GST proceedings, resulting in a ₹2.0 crore net financial impact. A further ₹9.9 crore liability is recoverable as Input Tax Credit.
- Value
- ₹11.90 Cr
Clean Science & Technology Credit Rating
CRISIL reaffirmed Clean Science's long-term rating at AA-/Stable and short-term at A1+. The rating action signals continued stable credit quality with no change.
Clean Science & Technology Legal & Regulatory
GST authorities initiated search and seizure proceedings at the company's premises. The company reports no material impact on financials or business operations at this stage.
Clean Science & Technology Acquisition Worth ₹50 Cr
Clean Science and Technology invested Rs. 50.00 Crore to subscribe to additional equity shares of its wholly-owned subsidiary, Clean Fino-Chem Limited, for project funding.
- Value
- ₹50.00 Cr
Clean Science & Technology Management Change
Clean Science and Technology Limited has appointed Mr. Krishnakumar Satyanarain Saboo as an Executive Director, effective August 1, 2026, for a five-year term.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.